ANI Pharmaceuticals, Inc. acquired Portfolio of NDAs and ANDA of Sandoz Inc. for $20.7 million.
April 05, 2021
Share
ANI Pharmaceuticals, Inc. (NasdaqGM:ANIP) acquired Portfolio of NDAs and ANDA of Sandoz Inc. for $20.7 million on April 1, 2021. The purchase price is $18.5 million plus approximately $2.2 million for the purchase of API and finished goods inventory. As part of the transaction, ANI has acquired the new drug applications (“NDAs”) for OXISTAT® Lotion, VEREGEN® Ointment, and Pandel® Cream and the abbreviated new drug application (“ANDA”) for ApexiCon® E Cream. Pandel® Cream will be transitioned later upon receiving the requisite approvals. The acquisition was funded by a $24.0 million borrowing under the company’s pre-existing revolver credit facility, which was drawn on April 1, 2021. Collectively, these products generated net revenues of $13.2 million in 2020. The transaction is an accretive one which is in line with growth strategy laid out for Branded Products business.
ANI Pharmaceuticals, Inc. (NasdaqGM:ANIP) completed the acquisition of Portfolio of NDAs and ANDA of Sandoz Inc. on April 1, 2021.
ANI Pharmaceuticals, Inc. is a diversified biopharmaceutical company, which serves patients in need by developing, manufacturing and marketing branded and generic prescription pharmaceutical products, including for diseases with high unmet medical need. Its three pharmaceutical manufacturing facilities, of which two are located in Baudette, Minnesota, and one is located in East Windsor, New Jersey, are together capable of producing oral solid dose products, as well as semi-solids, liquids and topicals, controlled substances, and potent products. The Company has a commercial portfolio of 116 products with a variety of indications and a robust portfolio of pipeline products. It has acquired the NDAs for and market Atacand, Atacand HCT, Arimidex, Casodex, Lithobid, Vancocin, Inderal LA, Inderal XL, InnoPran XL, Oxistat, Veregen, and Pandel. The Company sources the raw materials for its products from both domestic and international suppliers.
ANI PHARMACEUTICALS, INC. 
